The morbidity and mortality of CRC are higher in men than in women because estrogen is associated with various growth factors affecting cell proliferation and microscopic changes in the cell immune response by binding estrogen receptor beta (ERβ) in the colon [34]. Here, ESR2 is linked to colorectal carcinoma.